Connection
Rama Kant to Neovascularization, Pathologic
This is a "connection" page, showing publications Rama Kant has written about Neovascularization, Pathologic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.122 |
|
|
|
-
da Silva RF, Dhar D, Raina K, Kumar D, Kant R, Cagnon VHA, Agarwal C, Agarwal R. Nintedanib inhibits growth of human prostate carcinoma cells by modulating both cell cycle and angiogenesis regulators. Sci Rep. 2018 06 22; 8(1):9540.
Score: 0.122